IDEXX Laboratories, Inc.
IDXX
$579.85
$2.730.47%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Revenue | 4.30B | 4.17B | 4.04B | 3.93B | 3.90B |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 4.30B | 4.17B | 4.04B | 3.93B | 3.90B |
| Cost of Revenue | 1.64B | 1.60B | 1.55B | 1.52B | 1.52B |
| Gross Profit | 2.66B | 2.57B | 2.48B | 2.41B | 2.38B |
| SG&A Expenses | 1.04B | 1.02B | 996.99M | 975.61M | 969.30M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 2.93B | 2.86B | 2.78B | 2.72B | 2.71B |
| Operating Income | 1.37B | 1.31B | 1.26B | 1.21B | 1.19B |
| Income Before Tax | 1.32B | 1.27B | 1.23B | 1.12B | 1.11B |
| Income Tax Expenses | 264.73M | 246.17M | 242.08M | 229.47M | 221.96M |
| Earnings from Continuing Operations | 1.06K | 1.03K | 985.66 | 894.97 | 887.87 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 1.06B | 1.03B | 985.66M | 894.97M | 887.87M |
| EBIT | 1.37B | 1.31B | 1.26B | 1.21B | 1.19B |
| EBITDA | 1.51B | 1.45B | 1.39B | 1.34B | 1.32B |
| EPS Basic | 13.18 | 12.71 | 12.11 | 10.91 | 10.77 |
| Normalized Basic EPS | 10.36 | 9.85 | 9.43 | 9.04 | 8.87 |
| EPS Diluted | 13.08 | 12.61 | 12.01 | 10.82 | 10.67 |
| Normalized Diluted EPS | 10.29 | 9.77 | 9.35 | 8.96 | 8.79 |
| Average Basic Shares Outstanding | 321.73M | 323.67M | 325.88M | 328.10M | 329.88M |
| Average Diluted Shares Outstanding | 324.07M | 326.13M | 328.51M | 330.91M | 332.94M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |